Somatostatin Receptor Type 2–Based Reporter Expression after Plasmid-Based in Vivo Gene Delivery to Non–Small Cell Lung Cancer
Plasmids tend to have much lower expression than viruses. Gene expression after systemic administration of plasmid vectors has not been assessed using somatostatin receptor type 2 ( SSTR2 )-based reporters. The purpose of this work was to identify gene expression in non–small cell lung cancer (NSCLC...
Main Authors: | Lin Han, Murali Ravoori, Guanglin Wu, Ryo Sakai, Shaoyu Yan, Sheela Singh, Kai Xu, Jack A. Roth, Lin Ji, Vikas Kundra |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-10-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2013.00060 |
Similar Items
-
Signaling Can Be Uncoupled from Imaging of the Somatostatin Receptor Type 2
by: Lin Han, et al.
Published: (2007-11-01) -
In vivo magnetic resonance imaging of orthotopic prostate cancer
by: Murali K Ravoori, et al.
Published: (2020-07-01) -
Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability
by: Xabier Guarrochena, et al.
Published: (2024-03-01) -
Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
by: Maria Isabel del Olmo-Garcia, et al.
Published: (2021-12-01) -
Somatostatin receptors in fibrotic myocardium.
by: Estibaliz Castillero, et al.
Published: (2024-01-01)